Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients

References

• Risma KA, Marsh RA. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis. J Allergy Clin Immunol Pract. 2019;7(3):824–832.
   PubMed Web of Science ®Google Scholar
• Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332–1343.
   PubMed Web of Science ®Google Scholar
• Yao S, Wang Y, Sun Y, et al. Epidemiological investigation of hemophagocytic lymphohistiocytosis in China. Orphanet J Rare Dis. 2021;16(1):342.
   PubMed Web of Science ®Google Scholar
• Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr. 2016;4:47.
   PubMed Web of Science ®Google Scholar
• Kim YR, Kim DY. Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults. Blood Res. 2021;56(S1): S17–S25.
   PubMedGoogle Scholar
• Imashuku S, Morimoto A, Ishii E. Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr. 2021;110(10):2729–2736.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Park SS, Jeon YW, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269–276.
   PubMed Web of Science ®Google Scholar
• El-Mallawany NK, McClain KL. Checkmate for EBV-HLH. Blood. 2020;135(11):782–784.
   PubMed Web of Science ®Google Scholar
• Henter J-I, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Sitter T. Kreatinin und glomeruläre filtrationsrate (GFR): serie laborparameter, folge 6 [serum creatinine and estimated glomerular filtration rate]. MMW Fortschr Med. 2021;163(10):50–51.
   PubMedGoogle Scholar
• Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–2620.
   PubMed Web of Science ®Google Scholar
• Fluss R, Faraggi D, Reiser B. Estimation of the youden index and its associated cutoff point. Biom J. 2005;47(4):458–472.
   PubMed Web of Science ®Google Scholar
• Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817–825.
   PubMed Web of Science ®Google Scholar
• Hutchinson M, Tattersall RS, Manson JJ. Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome. Rheumatology. 2019;58(Suppl 6):vi23–vi30.
   PubMedGoogle Scholar
• Gao Z, Wang Y, Wang J, et al. The inhibitory receptors on NK cells and CTLs are upregulated in adult and adolescent patients with secondary hemophagocytic lymphohistiocytosis. Clin Immunol. 2019;202:18–28.
   PubMed Web of Science ®Google Scholar
• Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651–658.
   PubMed Web of Science ®Google Scholar
• Annels NE, Kalpoe JS, Bredius RG, et al. Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution. Clin Infect Dis. 2006;42(12):1743–1748.
   PubMed Web of Science ®Google Scholar
• La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
   PubMed Web of Science ®Google Scholar
• Gualdoni GA, Hofmann GA, Wohlfarth P, et al. Prevalence and outcome of secondary hemophagocytic lymphohistiocytosis among SIRS patients: results from a prospective cohort study. JCM. 2019;8(4):541.
   Google Scholar
• Debaugnies F, Mahadeb B, Nagant C, et al. Biomarkers for early diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients. J Clin Immunol. 2021;41(3):658–665.
   PubMed Web of Science ®Google Scholar
• Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician. Blood Rev. 2009;23(3):95–104.
   PubMed Web of Science ®Google Scholar
• Sarangi R, Pathak M, Padhi S, et al. Ferritin in hemophagocytic lymphohistiocytosis (HLH): current concepts and controversies. Clin Chim Acta. 2020;510:408–415.
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Hock KG, Riley SB, et al. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol. 2017;96(10):1667–1672.
   PubMed Web of Science ®Google Scholar
• Hua Z, He L, Zhang R, et al. Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy. Ann Med. 2022;54(1):283–292.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu SS, Li SG, et al. Establishment of a protein biochip to detect serum IgG antibodies against IL-2 and soluble CD25 in hemophagocytic lymphohistiocytosis. Clin Chim Acta. 2018;487:256–263.
   PubMed Web of Science ®Google Scholar
• Zoref-Lorenz A, Murakami J, Hofstetter L, et al. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022;139(7):1098–1110.
   PubMed Web of Science ®Google Scholar
• Cleland DA, Eranki AP. Procalcitonin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Becker KL, Nylén ES, White JC, Jr., et al. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89(4):1512–1525.
   PubMed Web of Science ®Google Scholar
• Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(Suppl 1):S57–S61.
   PubMed Web of Science ®Google Scholar
• Aulagnon F, Lapidus N, Canet E, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis. 2015;65(6):851–859.
   PubMed Web of Science ®Google Scholar
• Cui Y, Shi J, Lu G, et al. Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: a multicenter prospective nested case-control study. Ther Apher Dial. 2022;26(5):1023–1029.
   PubMed Web of Science ®Google Scholar
• Yan WL, Yang SL, Zhao FY, et al. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: a case report. J Oncol Pharm Pract. 2022;28(1):222–227.
   PubMed Web of Science ®Google Scholar
• Inker LA, Titan S. Measurement and estimation of GFR for use in clinical practice: core curriculum 2021. Am J Kidney Dis. 2021;78(5):736–749.
   PubMed Web of Science ®Google Scholar
• Bergsten E, Horne A, Hed Myrberg I, et al. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study. Blood Adv. 2020;4(15):3754–3766.
   PubMed Web of Science ®Google Scholar